Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Overview of attention for article published in Frontiers in Pediatrics, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in The Pediatric Infectious Disease Journal (May 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.